Archive for November 13th, 2008

Pediatric News - Increlex, Singulair.(New & Approved)

Thursday, November 13th, 2008

Increlex

(mecasermin [rDNA origin] injection, Tercica Inc.)

The Food and Drug Administration approved Increlex for long-term treatment of growth failure in children 2 years or older with severe primary insulinlike growth factor-1 (IGF-1) deficiency or with growth hormone gene deletion.

* Recommended dosage: Starting dose is 0.04-0.08 mg/kg twice daily…